Status | Study |
Completed |
Study Name: Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes M Date: 2003-11-04 Interventions: Drug: vatalanib Pts registered before 1/15/05 1250 mg/day PO After 1/15/05: Start w/ 750 mg/day PO; esca |
Completed |
Study Name: Cholecalciferol in Treating Patients With Myelodysplastic Syndrome Condition: Leukemia Myelodysplastic Syndromes M Date: 2003-09-10 Interventions: Dietary Supplement: cholecalciferol |
Terminated |
Study Name: Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia Condition: Chronic Myeloproliferative Disorders Leukemia Date: 2003-08-06 Interventions: Drug: cyclophosphamide Drug: cyclosporine |
Completed |
Study Name: Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS Condition: Leukemia Myelodysplastic Syndromes M Date: 2003-01-27 Interventions: Drug: carboplatin Carboplatin |
Completed |
Study Name: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Condition: Leukemia Myelodysplastic Syndromes M Date: 2003-01-24 Interventions: Dietary Supplement: doxercalciferol |
Completed |
Study Name: Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome Condition: Leukemia Myelodysplastic/Myeloproliferative Neoplasms Date: 2002-10-03 Interventions: Drug: cytarabine Drug: mercaptopurine |
Completed |
Study Name: Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer Condition: Leukemia Myelodysplastic Syndromes M Date: 2000-09-11 Interventions: Drug: sodium phenylbutyrate Drug: tretinoi |
Terminated |
Study Name: Tipifarnib in Treating Patients With Myeloproliferative Disorders Condition: Leukemia Myelodysplastic/Myeloproliferative Neoplasms Date: 2000-06-02 Interventions: Drug: tipifarnib |
Completed |
Study Name: Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Condition: Leukemia Myelodysplastic Syndromes M Date: 2000-03-07 Interventions: Biological: filgrastim Drug: busulfan |
Completed |
Study Name: Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Condition: Leukemia Myelodysplastic Syndromes M Date: 2000-03-07 Interventions: Drug: busulfan Drug: cyclophosphamide |